Swedish Orphan Biovitrum AB (publ) (FRA:B6E)

FRA:B6E Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	13,026	10,599	9,620	8,250	5,805	5,382
Market Cap Growth	30.07%	10.18%	16.61%	42.11%	7.87%	10.38%
Enterprise Value	14,006	11,759	11,129	10,084	6,693	6,500
Last Close Price	37.72	30.76	27.66	24.14	18.33	16.90
PE Ratio	294.92	239.96	28.37	38.07	24.52	20.66
PS Ratio	4.99	4.06	4.24	4.14	3.44	3.56
PB Ratio	3.74	3.04	2.74	2.71	2.44	2.38
P/FCF Ratio	16.54	13.46	15.27	25.50	14.36	10.21
P/OCF Ratio	16.46	13.39	14.92	20.52	14.13	10.12
EV/Sales Ratio	5.30	4.51	4.90	5.07	3.97	4.31
EV/EBITDA Ratio	13.02	11.08	13.74	14.87	11.31	11.93
EV/EBIT Ratio	18.69	15.90	21.90	24.09	16.50	17.62
EV/FCF Ratio	17.78	14.93	17.67	31.16	16.56	12.33
Debt / Equity Ratio	0.31	0.31	0.42	0.61	0.34	0.47
Debt / EBITDA Ratio	1.00	1.00	1.78	2.67	1.36	1.91
Debt / FCF Ratio	1.35	1.35	2.32	5.70	2.02	2.01
Net Debt / Equity Ratio	0.28	0.28	0.39	0.58	0.29	0.43
Net Debt / EBITDA Ratio	0.91	0.91	1.68	2.60	1.17	1.76
Net Debt / FCF Ratio	1.23	1.23	2.16	5.44	1.72	1.82
Asset Turnover	0.40	0.40	0.35	0.35	0.37	0.32
Inventory Turnover	1.29	1.29	1.42	1.38	1.31	1.08
Quick Ratio	0.59	0.59	0.68	0.42	0.51	0.59
Current Ratio	0.90	0.90	1.05	0.64	0.76	1.00
Return on Equity (ROE)	1.22%	1.22%	10.46%	7.98%	10.61%	12.34%
Return on Assets (ROA)	7.00%	7.00%	4.87%	4.60%	5.58%	4.89%
Return on Invested Capital (ROIC)	16.55%	15.38%	9.38%	8.65%	10.66%	9.15%
Return on Capital Employed (ROCE)	15.60%	15.60%	9.30%	8.50%	12.00%	9.50%
Earnings Yield	0.34%	0.42%	3.52%	2.63%	4.08%	4.84%
FCF Yield	6.05%	7.43%	6.55%	3.92%	6.96%	9.80%
Buyback Yield / Dilution	-0.59%	-0.59%	-6.01%	-9.22%	-0.56%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.